Navigation Links
Scientists in Singapore and Europe to collaborate
Date:10/13/2011

HEIDELBERG -- Scientists in Singapore and Europe will have new avenues for scientific interaction, following a cooperation agreement between EMBO, its intergovernmental funding body, EMBC, and the government of Singapore. The agreement will allow Singapore scientists to participate in EMBO training programmes and activities. It also means that EMBO workshops and lectures can take place in Singapore. This is the first cooperation agreement of its kind between EMBO, EMBC and Singapore.

"EMBO promotes and encourages the development of the life sciences within Europe and beyond. We welcome the opportunity to ensure the mobility of scientists between Singapore and Europe and we look forward to the scientific collaboration that this agreement will bring," said EMBO Director Maria Leptin.

Chairman of the Singapore Agency for Science, Technology and Research (A*STAR), Mr Lim Chuan Poh, said that Singapore shared the same vision. "We are confident that this agreement will spur international collaborations in world-class scientific research, which will pave the way for new biomedical discoveries and global healthcare solutions."

A*STAR represented Singapore in negotiations. The agreement brings together major players in Singapore's biomedical research scene, namely A*STAR, the National University of Singapore (NUS) and the Nanyang Technological University (NTU).

New opportunities for scientific interaction

Under the agreement, scientists can apply for EMBO Short-Term and Long-Term Fellowships to work in Singapore or Europe. Scientists from Singapore can apply to the EMBO Young Investigator Programme, which provides outstanding young scientists with financial, academic and practical support to start up their first independent research laboratories.

Singapore and EMBO will also cooperate in the organization of an EMBO Workshop in Singapore, which will help to spark cross-disciplinary collaborations. The workshop organizers from Singapore and Europe can apply for funding for an EMBO Member or Young Investigator as plenary lecturer at their event. Other conferences in Singapore can also apply for the support of an EMBO Member or Young Investigator as speaker.

The cooperation agreement will run for three years.

Singapore and EMBO: a growing relationship

The cooperation agreement builds on a growing series of exchanges between Singapore and scientists associated with EMBO. Key EMBO Members based in Singapore include NTU President Professor Bertil Andersson; A*STAR Chief Scientist, Professor Sir David Lane; Chairman of A*STAR's Biomedical Research Council, Professor Sir George Radda; and NTU Professor of Biological Sciences and Chair of EMBO Council, Daniela Rhodes. Since 2005, there have been eight EMBO-funded events in Singapore, including a 2011 Plenary Lecture. In 2009, 12 EMBO Gold Medalists presented their work and held discussions with 300 researchers based in Singapore on a range of topics in developmental, cell and molecular biology.


'/>"/>
Contact: Suzanne Beveridge
communications@embo.org
European Molecular Biology Organization
Source:Eurekalert

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: